MIOGGI Magic Advanced Skin Essential Activator

Manufacturer
Colorpink R&D Inc.
Effective date
2012-08-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:33:15

Label at a glance#

ProductMIOGGI Magic Advanced Skin Essential Activator
Active ingredientADENOSINE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ADENOSINE

INACTIVE INGREDIENT SECTION

Water, Methylsilanol mannuronate, Beta-glucan, Butylene glycol, Propanediol, PEG-60 hydrogenated castor oil, Morus alba root extract, Diospyros kaki leaf extract, Camellia sinensis leaf extract, Aloe barbadensis leaf extract, Dipotassium glycyrrhizate, Allantoin, Sodium hyaluronate, Adenosine, Sodium carbomer, Uncaria sinensis extract, Portulaca oleracea extract, Paeonia lactiflora root extract, Hamamelis virginiana(Witch hazel) bark/leaf/twig extract, Ginkgo biloba  leaf extract, Citrus aurantium amara (Bitter orange) fruit extract, Rehmannia glutinosa root extract, Paeonia suffruticosa bark extract, Dryopteris crassirhizoma extract, Dryopteris filix-mas root extract, Cnidium officinale root extract, Cimicifuga racemosa root extract, Angelica acutiloba root extract, Macadamia ternifolia seed oil, Caprylic/capric triglyceride, Glycerin, PEG-5 rapeseed sterol, Cholesterol, Brassica campestris (Rapeseed) sterols, Beta-sitosterol, Saccharide isomerate, Hydrogenated lecithin, Ceramide 3, Choleth-24, Ceteth-24, Aronia melanocarpa fruit extract, Dextran, Polyglutamic acid, Creatine, Cetyl phosphate, Caprooyl tetrapeptide-3, Carthamus tinctorius (Safflower) seed extract, Disodium EDTA, Phenoxyethanol, Methylparaben, Proplyparaben, BHT, Fragrance

OTC - PURPOSE SECTION

for improving skin wrinkles

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

Apply every morning and evening after cleansing.
Dispense a generous amount onto palm, gently pat and massage over face until fully absorbed

WARNINGS SECTION

1.  In case of having following symptoms after using this, you're advised to stop using it immediately. If you keep using it, the symptoms will get worse and need to consult a dermatologist.
    A. In case of having problems such as red rash, swollenness, itching, stimulation during usage.
    B. In case of having the same symptoms above on the part you put this product on by direct sunlight.
2.    You are banned to use it on the part where you have a scar, eczema, or dermatitis.
3.    Caution for treatment and keeping.
    A. Tighten the lid after using it.
    B.  Keep it out of infants or children's reach.
    C. Don't keep it in the place where the temperature is extremely hot or low and exposed to the direct sunlight.

DOSAGE & ADMINISTRATION SECTION

- for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package label
package label

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53009-2001-12019-11-27C16284748780-19855d018-d919-cd31-e053-dbdaa90ab51aDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53009-2001-1MIOGGI Magic Advanced Skin Essential Activator125 mL in 1 BOTTLE, GLASSLIQUID1251

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53009-2001MIOGGI MAGIC ADVANCED SKIN ESSENTIAL ACTIVATOR (ADENOSINE) LIQUID [COLORPINK R&D INC.]1Legacy NDC, 1 package rows20121011_7a0265cb-9475-4740-9dd4-5fe2005876c9.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ADENOSINEACTIVE INGREDIENTK72T3FS5671
ADENOSINEACTIVE MOIETYK72T3FS5671
.BETA.-SITOSTEROLINACTIVE INGREDIENTS347WMO6M41
ALLANTOININACTIVE INGREDIENT344S277G0Z1
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0X1
ANGELICA ACUTILOBA ROOTINACTIVE INGREDIENT3W51R3EK301
ARONIA MELANOCARPA FRUITINACTIVE INGREDIENTS935718Z2Q1
BITTER ORANGE OILINACTIVE INGREDIENT9TLV70SV6I1
BLACK COHOSHINACTIVE INGREDIENTK73E24S6X91
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K1
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA1
CAPROOYL TETRAPEPTIDE-3INACTIVE INGREDIENTLZI0HJ3K2R1
CARTHAMUS TINCTORIUS SEEDCAKEINACTIVE INGREDIENTDHQ13F4N2W1
CERAMIDE 3INACTIVE INGREDIENT4370DF050B1
CETETH-24INACTIVE INGREDIENT0EV3Z43Y2I1
CETYL PHOSPHATEINACTIVE INGREDIENTVT07D6X67O1
CHOLESTEROLINACTIVE INGREDIENT97C5T2UQ7J1
CHOLETH-24INACTIVE INGREDIENT5UE7I54O431
CNIDIUM OFFICINALE ROOTINACTIVE INGREDIENT8S3OZD358J1
CREATINEINACTIVE INGREDIENTMU72812GK01
DEXTRAN 40INACTIVE INGREDIENTK3R6ZDH4DU1
DIOSPYROS KAKI LEAFINACTIVE INGREDIENTQ71GF9OBNO1
DRYOPTERIS CRASSIRHIZOMA WHOLEINACTIVE INGREDIENTV3B80C759E1
DRYOPTERIS FILIX-MAS ROOTINACTIVE INGREDIENTC0ZK0RRF5X1
GINKGOINACTIVE INGREDIENT19FUJ2C58T1
GLYCERININACTIVE INGREDIENTPDC6A3C0OX1
GLYCYRRHIZINATE DIPOTASSIUMINACTIVE INGREDIENTCA2Y0FE3FX1
GREEN TEA LEAFINACTIVE INGREDIENTW2ZU1RY8B01
HYALURONATE SODIUMINACTIVE INGREDIENTYSE9PPT4TH1
HYDROGENATED SOYBEAN LECITHININACTIVE INGREDIENTH1109Z9J4N1
MACADAMIA NUTINACTIVE INGREDIENTY5432RGW8N1
MEDIUM-CHAIN TRIGLYCERIDESINACTIVE INGREDIENTC9H2L21V7U1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T1
MORUS ALBA ROOTINACTIVE INGREDIENTCST1G9BZGD1
PAEONIA LACTIFLORA ROOTINACTIVE INGREDIENT3Z3866YW6P1
PAEONIA SUFFRUTICOSA ROOT BARKINACTIVE INGREDIENTBUG255FE7X1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T1
POLYOXYL 60 CASTOR OILINACTIVE INGREDIENTVXP26NM2XX1
PORTULACA OLERACEA WHOLEINACTIVE INGREDIENTD5J3623SV21
PROPANEDIOLINACTIVE INGREDIENT5965N8W85T1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH1
RAPESEED STEROLINACTIVE INGREDIENTB46B6DD20U1
REHMANNIA GLUTINOSA ROOTINACTIVE INGREDIENT1BEM3U6LQQ1
SACCHARIDE ISOMERATEINACTIVE INGREDIENTW8K377W98I1
UNCARIA SINENSIS WHOLEINACTIVE INGREDIENT69OQ216G2K1
WITCH HAZELINACTIVE INGREDIENT101I4J0U341

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 46 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53009-200153009-2001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 45 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 302 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
GLYCERINGLYCERINPDC6A3C0OXELIXIR / ORAL5621 mgExact identifier — unii candidate
75 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KOINTMENT / TOPICAL57 mgExact identifier — unii candidate
32 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCONCENTRATE / ORAL1800 mgExact identifier — unii candidate
75 equally ranked IID candidates
HYALURONATE SODIUMHYALURONATE SODIUMYSE9PPT4THINJECTION, SUSPENSION / INTRAMUSCULAR23 mgExact identifier — unii candidate
5 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / TOPICAL3000 mgExact identifier — unii candidate
79 equally ranked IID candidates
HYALURONATE SODIUMHYALURONATE SODIUMYSE9PPT4THGEL / TOPICAL463 mgExact identifier — unii candidate
5 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / NASAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYSTEM / IONTOPHORESIS168.1 mgExact identifier — unii candidate
75 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSUPPOSITORY / RECTAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXJELLY / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TOINTMENT / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / VAGINAL22 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / AURICULAR (OTIC)NAExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGRANULE, FOR SUSPENSION / ORAL80 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET, CHEWABLE / ORAL0.14 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSHAMPOO / TOPICAL0.15 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KAEROSOL, FOAM / TOPICAL4 mgExact identifier — unii candidate
32 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, LIQUID FILLED / ORAL185 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / ORAL100 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXMOUTHWASH / BUCCAL100 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
CHOLETH-24CHOLETH-245UE7I54O43EMULSION / TOPICAL5 %w/wExact identifier — unii candidate
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KGEL / TOPICAL8 mgExact identifier — unii candidate
32 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7ULOTION / TOPICAL7 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / ORAL26208 mgExact identifier — unii candidate
75 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSHAMPOO / TOPICAL0.1 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXEMULSION / INTRAVENOUS2.2 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / INTRAVENOUS6 mgExact identifier — unii candidate
68 equally ranked IID candidates
CHOLESTEROLCHOLESTEROL97C5T2UQ7JINJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS0.32 %w/vExact identifier — unii candidate
10 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCONCENTRATE / ORAL2.5 mg/5mlExact identifier — unii candidate
68 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCREAM / VAGINAL0.05 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UOINTMENT / TOPICAL20 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHLIQUID / TOPICAL0.1 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSPRAY / NASAL0.2 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TENEMA / RECTAL0.18 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
HYDROGENATED SOYBEAN LECITHINHYDROGENATED SOYBEAN LECITHINH1109Z9J4NTABLET / ORAL0.21 mgExact identifier — unii candidate
4 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UPOWDER, FOR SUSPENSION / ORAL3390 mg/5mlExact identifier — unii candidate
18 equally ranked IID candidates
CHOLESTEROLCHOLESTEROL97C5T2UQ7JLOTION / TOPICAL20 mgExact identifier — unii candidate
10 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / INTRAVENOUS0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLOTION / TOPICAL3990 mgExact identifier — unii candidate
75 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TJELLY / TOPICAL420 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHEMULSION / TOPICAL0.06 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION, EXTENDED RELEASE / ORAL2000 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHDROPS / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TELIXIR / ORAL800 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET, EXTENDED RELEASE / ORAL0.17 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / EPIDURAL1 mgExact identifier — unii candidate
79 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USOLUTION / ORAL5566 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHPASTE, DENTIFRICE / DENTALNAExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRAMUSCULAR450 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSPRAY / TOPICAL0.8 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHJELLY / TOPICAL180 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXAEROSOL / TOPICAL3 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
MEDIUM-CHAIN TRIGLYCERIDESMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USPRAY, METERED / SUBLINGUAL110 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / SOFT TISSUE0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / DENTAL20 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM, AUGMENTED / TOPICAL55 mgExact identifier — unii candidate
75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2c6f47a0-36a3-4fd0-a303-d409f91031e07a0265cb-9475-4740-9dd4-5fe2005876c92012-08-20WarningsExact identifier
spl id: 2c6f47a0-36a3-4fd0-a303-d409f91031e0
spl set id: 7a0265cb-9475-4740-9dd4-5fe2005876c9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.